On August 30, 2023 Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) reported that Raul Rodriguez, the company’s president and chief executive officer, and Dean Schorno, the company’s chief financial officer, will participate in the following investor conferences in September (Press release, Rigel, AUG 30, 2023, View Source [SID1234634777]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2023 Wells Fargo Healthcare Conference, September 6-8, 2023, Boston, MA
Raul Rodriguez will present a company overview on Wednesday, September 6th at 12:45 p.m. ET.

Citi’s 18th Annual BioPharma Conference, September 6-7, 2023, Boston, MA
Rigel management will participate in one-on-one meetings on Thursday, September 7th.

To access the live webcast of the Wells Fargo Healthcare Conference presentation, visit the Investor Relations section of the company’s website at www.rigel.com. Please connect to Rigel’s website prior to the start of the live webcast to allow for any software downloads.